Mitotic phosphorylation activates hepatoma-derived growth factor as a mitogen

BMC Cell Biology

Volumn 12, Issue , 2011, Pages

  Everett, Allen D ^a   Yang, Jun ^a   Rahman, Monzur ^a   Dulloor, Pratima ^a   Brautigan, David L ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; HEPATOMA DERIVED GROWTH FACTOR; MITOGENIC AGENT; NOCODAZOLE; HEPATOMA-DERIVED GROWTH FACTOR; SIGNAL PEPTIDE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANTIBODY SPECIFICITY; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL PROLIFERATION; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; MITOSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; ANIMAL; CELL LINE; CHEMISTRY; GENETICS; HUMAN; METABOLISM; PHOSPHORYLATION; PROTEIN MOTIF; RAT;

AMINO ACID MOTIFS; ANIMALS; CELL LINE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MITOGENS; MITOSIS; PHOSPHORYLATION; RATS;

EID: 79953880876     PISSN: None     EISSN: 14712121     Source Type: Journal    
DOI: 10.1186/1471-2121-12-15     Document Type: Article

References (22)

1. Everett AD, Lobe DR, Matsumura ME, Nakamura H, McNamara CA. Hepatoma-derived growth factor stimulates smooth muscle cell growth and is expressed in vascular development. J Clin Invest 2000, 105:567-575. 10.1172/JCI7497, 289171, 10712428.
2. Nakamura H, Izumoto Y, Kambe H, Kuroda T, Mori T, Kawamura K, Yamamoto H, Kishimoto T. Molecular cloning of complementary DNA for a novel human hepatoma-derived growth factor. Its homology with high mobility group-1 protein. J Biol Chem 1994, 269:25143-25149.
3. Oliver JA, Al-Awqati Q. An endothelial growth factor involved in rat renal development. J Clin Invest 1998, 102:1208-1219. 10.1172/JCI785, 509104, 9739055.
4. Everett AD, Stoops T, McNamara CA. Nuclear targeting is required for hepatoma-derived growth factor-stimulated mitogenesis in vascular smooth muscle cells. J Biol Chem 2001, 276:37564-37568. 10.1074/jbc.M105109200, 11481329.
5. Kishima Y, Yamamoto H, Izumoto Y, Yoshida K, Enomoto H, Yamamoto M, Kuroda T, Ito H, Yoshizaki K, Nakamura H. Hepatoma-derived growth factor stimulates cell growth after translocation to the nucleus by nuclear localization signals. J Biol Chem 2002, 277:10315-10322. 10.1074/jbc.M111122200, 11751870.
6. Abouzied MM, Baader SL, Dietz F, Kappler J, Gieselmann V, Franken S. Expression patterns and different subcellular localization of the growth factors HDGF (hepatoma-derived growth factor) and HRP-3 (HDGF-related protein-3) suggest functions in addition to their mitogenic activity. Biochem J 2004, 378:169-76. 10.1042/BJ20030916, 1223924, 14572309.
7. Everett AD, Narron JV, Stoops T, Nakamura H, Tucker A. Hepatoma-derived growth factor is a pulmonary endothelial cell-expressed angiogenic factor. Am J Physiol Lung Cell Mol Physiol 2004, 286:L1194-201. 10.1152/ajplung.00427.2003, 14751852.
8. Mori M, Morishita H, Nakamura H, Matsuoka H, Yoshida K, Kishima Y, Zhou Z, Kida H, Funakoshi T, Goya S, Yoshida M, Kumagai T, Tachibana I, Yamamoto Y, Kawase I, Hayashi S. Hepatoma-derived growth factor is involved in lung remodeling by stimulating epithelial growth. Am J Respir Cell Mol Biol 2004, 30:459-69. 10.1165/rcmb.2003-0013OC, 12972397.
9. Narron JV, Stoops TD, Barringhaus K, Matsumura M, Everett AD. Hepatoma Derived Growth Factor Is Rapidly Expressed After Vascular Injury and Stimulates Smooth Muscle Cell Migration. Peds Res 2006, 59:778-783.
10. Ren H, Tang X, Lee JJ, Feng L, Everett AD, Hong WK, Khuri FR, Mao L. Expression of hepatoma-derived growth factor is a strong prognostic predictor for patients with early-stage non-small-cell lung cancer. J Clin Oncol 2004, 22:3230-7. 10.1200/JCO.2004.02.080, 15310766.
11. Uyama H, Tomita Y, Nakamura H, Nakamori S, Zhang B, Hoshida Y, Enomoto H, Okuda Y, Sakon M, Aozasa K, Kawase I, Hayashi N, Monden M. Hepatoma-derived growth factor is a novel prognostic factor for patients with pancreatic cancer. Clin Cancer Res 2006, 12(20 PT 1):6043-8. 10.1158/1078-0432.CCR-06-1064, 17062679.
12. Yamamoto S, Tomita Y, Hoshida Y, Morii E, Yasuda T, Doki Y, Aozasa K, Uyama H, Nakamura H, Monden M. Expression level of hepatoma-derived growth factor correlates with tumor recurrence of esophageal carcinoma. Ann Surg Oncol 2007, 14:2141-9. 10.1245/s10434-007-9369-9, 17473954.
13. Yoshida K, Tomita Y, Okuda Y, Yamamoto S, Enomoto H, Uyama H, Ito H, Hoshida Y, Aozasa K, Nagano H, Sakon M, Kawase I, Monden M, Nakamura H. Hepatoma-derived growth factor is a novel prognostic factor for hepatocellular carcinoma. Ann Surg Oncol 2006, 13:159-67. 10.1245/ASO.2006.11.035, 16411141.
14. Neganova I, Lako M. G1 to S phase cell cycle transition in somatic and embryonic stem cells. J Anat 2008, 213:30-44. 10.1111/j.1469-7580.2008.00931.x, 2475562, 18638068.
15. Bernard K, Litman E, Fitzpatrick JL, Shellman YG, Argast G, Polvinen K, Everett AD, Fukasawa K, Norris DA, Ahn NG, Resing KA. Functional proteomic analysis of melanoma progression. Cancer Res 2003, 63:6716-25.
16. Beausoleil SA, Jedrychowski M, Schwartz D, Elias JE, Villén J, Li J, Cohn MA, Cantley LC, Gygi SP. Large-scale characterization of HeLa cell nuclear phosphoproteins. Proc Natl Acad Sci USA 2004, 101:12130-5. 10.1073/pnas.0404720101, 514446, 15302935.
17. Kim JE, Tannenbaum SR, White FM. Global phosphoproteome of HT-29 human colon adenocarcinoma cells. J Proteome Res 2005, 4:1339-46. 10.1021/pr050048h, 16083285.
18. Schmid I, Sakamoto KM. Analysis of DNA content and green fluorescent protein expression. Curr Protoc Cytom 2001, ChaPTer 7:Unit 7.16.
19. Blom N, Sicheritz-Ponten T, GuPTa R, Gammeltoft S, Brunak S. Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence. Proteomics 2004, 4:1633-49. 10.1002/pmic.200300771, 15174133.
20. Salvi M, Sarno S, Cesaro L, Nakamura H, Pinna LA. Extraordinary pleiotropy of protein kinase CK2 revealed by weblogo phosphoproteome analysis. Biochim Biophys Acta 2009, 1793:847-59. 10.1016/j.bbamcr.2009.01.013, 19339213.
21. Yang J, Everett AD. Hepatoma-derived growth factor binds DNA through the N-terminal PWWP domain. BMC Mol Biol 2007, 8:101. 10.1186/1471-2199-8-101, 2176068, 17974029.
22. Shirohzu H, Kubota T, Kumazawa A, Sado T, Chijiwa T, Inagaki K, Suetake I, Tajima S, Wakui K, Miki Y, Hayashi M, Fukushima Y, Sasaki H. Three novel DNMT3B mutations in Japanese patients with ICF syndrome. Am J Med Genet 2002, 112:31-7. 10.1002/ajmg.10658, 12239717.